Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 25

    Merck to spin-off  biosimilar drugs business to focus on Keytruda

    Merck to spin-off biosimilar drugs business to focus on Keytruda

    Medical Dialogues Bureau7 Feb 2020 9:15 AM IST
    Merck will retain its cancer drugs, including blockbuster cancer therapy Keytruda, vaccines, hospital and animal health businesses, the company...
    Overcharging on Anti-diabetic, Cardiac Care Drugs: Rs 245.96 crore recovered from Pharma Firms, Minister informs Parliament

    Overcharging on Anti-diabetic, Cardiac Care Drugs: Rs 245.96 crore recovered from Pharma Firms, Minister informs Parliament

    Farhat Nasim6 Feb 2020 4:43 PM IST
    NPPA has detected and issued about 162 demand notices against the pharmaceutical companies for overcharging consumers on the sale of Anti-diabetic and...
    Lupin gets USFDA nod for generic version of Arava Tablets

    Lupin gets USFDA nod for generic version of Arava Tablets

    Medical Dialogues Bureau6 Feb 2020 1:08 PM IST
    Leflunomide Tablets USP is a generic equivalent of Arava Tablets, 10 mg and 20 mg, of Sanofi- Aventis, Lupin said.Mumbai: Pharma major Lupin Limited...
    Granules India sells entire stake in JV Biocause Pharma

    Granules India sells entire stake in JV Biocause Pharma

    Medical Dialogues Bureau6 Feb 2020 1:00 PM IST
    New Delhi: Drugmaker Granules India Ltd recently said it has divested its entire stake in Granules-Biocause Pharmaceutical Co Limited, a...
    Cipla Q3 revenue up by 13pc at Rs 4371 crore

    Cipla Q3 revenue up by 13pc at Rs 4371 crore

    Medical Dialogues Bureau6 Feb 2020 12:30 PM IST
    "We have had yet another good quarter: India business continued its momentum with strong double-digit growth in the prescription business; growth...
    Price-Fixing Conspiracies: Taro Pharma former executive faces probe in US

    Price-Fixing Conspiracies: Taro Pharma former executive faces probe in US

    Medical Dialogues Bureau6 Feb 2020 12:00 PM IST
    The Justice Department said that former sales and marketing executive of Taro Pharma, Aprahamian was indicted on Tuesday for participating in two...
    Sanofi being probed over birth defects related to Epilepsy drug Depakine

    Sanofi being probed over birth defects related to Epilepsy drug Depakine

    Medical Dialogues Bureau5 Feb 2020 3:35 PM IST
    The Paris prosecutor had already launched a preliminary investigation into the authorisation and marketing of Depakine in 2016, after France's...
    Granules India arm gets USFDA nod for generic version of  Valcyte

    Granules India arm gets USFDA nod for generic version of Valcyte

    Medical Dialogues Bureau5 Feb 2020 3:13 PM IST
    Valganciclovir hydrochloride oral solution is bioequivalent to the reference listed drug product (RLD), Valcyte for Oral Solution, 50mg/mL, OF Roche...
    Sun Pharma unveils acne drug Absorica LD in US

    Sun Pharma unveils acne drug Absorica LD in US

    Medical Dialogues Bureau5 Feb 2020 11:41 AM IST
    "The launch of Absorica LD - which offers the proven efficacy and safety of Absorica at a lower dose - underscores our commitment to making a...
    Cadila Healthcare Ahmedabad facility clears USFDA inspection

    Cadila Healthcare Ahmedabad facility clears USFDA inspection

    Farhat Nasim5 Feb 2020 9:15 AM IST
    United States Food and Drug Administration (USFDA) inspected the manufacturing facility of Alidac Pharmaceuticals, the company's wholly-owned...
    Zydus Cadila gets DGCI nod for diabetes drug Saroglitazar Magnesium

    Zydus Cadila gets DGCI nod for diabetes drug Saroglitazar Magnesium

    Farhat Nasim4 Feb 2020 10:30 AM IST
    "Zydus Cadila has received the approval from the Drug Controller General of India (DCGI) for use of Saroglitazar Mg in the treatment of type II...
    Divis Labs Chippada facility gets zero USFDA observations

    Divis Labs Chippada facility gets zero USFDA observations

    Medical Dialogues Bureau4 Feb 2020 9:45 AM IST
    "This is to inform you that the Company's Unit-II at Village Chippada, Bheemunipatnam District, Andhra Pradesh has had an inspection by the US Food...
    PrevNext

    Popular Stories

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok